{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:24:01Z","timestamp":1777321441696,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Nukada research scholarship"},{"name":"Toho University Sakura Medical center","award":["2015-033"],"award-info":[{"award-number":["2015-033"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jiac.2018.09.009","type":"journal-article","created":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T02:01:28Z","timestamp":1539396088000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations"],"prefix":"10.1016","volume":"25","author":[{"given":"Izumo","family":"Kanesaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Fujisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Mikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko Kanayama","family":"Katsuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longzhu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Intetsu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2018.09.009_bib1","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1128\/AAC.47.8.2538-2544.2003","article-title":"Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus","volume":"47","author":"Silverman","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.09.009_bib2","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1517\/13543784.8.8.1223","article-title":"Daptomycin: a novel agent for Gram-positive infection","volume":"8","author":"Tally","year":"1999","journal-title":"Expet Opin Invest Drugs"},{"key":"10.1016\/j.jiac.2018.09.009_bib3","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/AAC.00559-07","article-title":"Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis","volume":"51","author":"Julian","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.09.009_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10096-010-1128-3","article-title":"Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-na\u00efve patient -a review of the literature","volume":"30","author":"Van Hal","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2018.09.009_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/1471-2334-14-459","article-title":"First case report of vancomycin-intermediate sequence type 72 Staphylococcus aureus with nonsusceptibility to daptomycin","volume":"14","author":"Tsukimori","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2018.09.009_bib6","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1128\/AAC.01184-13","article-title":"Causal role of single nucleotide polymorphisms within the mprF gene of Staphylococcus aureus in daptomycin resistance","volume":"57","author":"Yang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.09.009_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09687688.2011.640948","article-title":"LC-MS\/MS characterization of phospholipid content in daptomycin-susceptible and -resistant isolates of Staphylococcus aureus with mutations in mprF","volume":"29","author":"Rubio","year":"2012","journal-title":"Mol Membr Biol"},{"key":"10.1016\/j.jiac.2018.09.009_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nyas.12948","article-title":"Mechanisms of drug resistance:daptomycin resistance","volume":"1354","author":"Tran","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jiac.2018.09.009_bib9","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1128\/AAC.00417-08","article-title":"Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype","volume":"12","author":"Camargo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.09.009_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10096-016-2581-4","article-title":"In\u00a0vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides","volume":"35","author":"Capone","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2018.09.009_bib11","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s10096-017-2999-3","article-title":"Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus","volume":"36","author":"Iwata","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2018.09.009_bib12","series-title":"Performance standards for antimicrobial susceptibility testing;26th informational supplement. Document M100-S26","year":"2016"},{"key":"10.1016\/j.jiac.2018.09.009_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.01133-16","article-title":"Complete genome sequence of Streptococcus pyogenes strain JMUB1235 isolated from an acute phlegmonous gastritis patient","volume":"4","author":"Watanabe","year":"2016","journal-title":"Genome Announc"},{"key":"10.1016\/j.jiac.2018.09.009_bib14","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/jac\/dkm375","article-title":"Daptomycin inoculum effects and mutant prevention concentration with Staphylococcus aureus","volume":"60","author":"Quinn","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2018.09.009_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.myc.2017.08.004","article-title":"Pendulichytrium sphaericum gen. et sp. nov. (Chytridiales, Chytriomycetaceae), a new chytrid parasitic on the diatom, Aulacoseira granulate","volume":"59","author":"Seto","year":"2018","journal-title":"Mycoscience"},{"key":"10.1016\/j.jiac.2018.09.009_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/AAC.00719-07","article-title":"Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, Membrane phospholipid asymmetry, and drug binding","volume":"52","author":"Jones","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.09.009_bib17","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1128\/AAC.01226-10","article-title":"Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-Alanylation","volume":"55","author":"Bertsche","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.09.009_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2958.2011.07576.x","article-title":"Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids","volume":"80","author":"Ernst","year":"2011","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.jiac.2018.09.009_bib19","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1128\/AAC.00160-15","article-title":"Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype","volume":"59","author":"Gaupp","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.09.009_bib20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.09.009_bib21","doi-asserted-by":"crossref","first-page":"e0198366","DOI":"10.1371\/journal.pone.0198366","article-title":"Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus","volume":"13","author":"Ma","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.jiac.2018.09.009_bib22","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1128\/AAC.03422-14","article-title":"Heterogeneity of mprF sequence in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides","volume":"58","author":"Bayer","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.09.009_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/CMR.00030-13","article-title":"A\u00a0current perspective on daptomycin for the clinical microbiologist","volume":"26","author":"Humphries","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2018.09.009_bib24","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/AAC.01121-07","article-title":"Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulation and genes responsive to membrane depolarization","volume":"52","author":"Muthaiyan","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.09.009_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1574-6968.2006.00281.x","article-title":"Activity of the major staphylococcal autolysin Atl","volume":"259","author":"Biswas","year":"2006","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.jiac.2018.09.009_bib26","doi-asserted-by":"crossref","first-page":"e29573","DOI":"10.1371\/journal.pone.0029573","article-title":"Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains","volume":"7","author":"Cafiso","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jiac.2018.09.009_bib27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1128\/AAC.00432-10","article-title":"VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in\u00a0vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus","volume":"56","author":"Mehta","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.09.009_bib28","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.3389\/fmicb.2017.02303","article-title":"Daptomycin resistance in clinical MRSA strains is associated with a high biological fitness cost","volume":"8","author":"Roch","year":"2017","journal-title":"Front Microbiol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18303313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18303313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:58:17Z","timestamp":1761159497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X18303313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1341321X18303313"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2018.09.009","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2018.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}